Bioasis Technologies Inc.
BIOAFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$7941
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Bioasis Technologies Inc. (BIOAF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOAF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-02 | 2021-02 | 2020-02 | 2019-02 | 2018-02 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.04M | $4.08M | $0.61M | $1.42M | $0.59M |
| Cost of Revenue | $1.23M | $1.24M | $0.00M | $0.01M | $0.47M |
| Gross Profit | ($1.19M) | $2.84M | $0.61M | $1.41M | $0.12M |
| Gross Margin %(computed) | — | 69.64% | 100.00% | 99.27% | 20.68% |
| Operating Expenses | |||||
| R&D Expenses | $1.23M | $1.24M | $2.03M | $1.95M | $0.95M |
| G&A Expenses | $2.41M | $2.46M | $3.17M | $4.31M | $4.45M |
| Total Operating Expenses | $3.63M | $3.70M | $5.21M | $6.27M | $5.40M |
| Operating Income | ($4.82M) | ($0.86M) | ($5.19M) | ($6.24M) | ($5.24M) |
| Operating Margin %(computed) | — | -21.04% | -856.53% | -438.75% | -887.56% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M |
| Interest Expense | $0.65M | $0.00M | $0.05M | $0.00M | $0.00M |
| Income Before Tax | ($2.96M) | $0.70M | ($4.06M) | ($3.47M) | ($5.31M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($1.38M) | $0.03M |
| Net Income | ($2.96M) | $0.70M | ($4.06M) | ($3.47M) | ($5.31M) |
| Net Margin %(computed) | — | 17.13% | -668.95% | -244.26% | -899.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $0.01 | $-0.07 | $-0.06 | $-0.10 |
| Wtd Avg Shares | 72.17M | 68.12M | 62.27M | 56.68M | 50.90M |
| EBITDA | ($3.54M) | $0.44M | ($4.54M) | ($4.79M) | ($5.22M) |
| EBITDA Margin %(computed) | — | 10.74% | -747.99% | -336.84% | -885.11% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Bioasis Technologies Inc. data
About Bioasis Technologies Inc. (BIOAF) Income Statement
Bioasis Technologies Inc. (BIOAF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, BIOAF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -3150.25%), and net income of ($0.00B) — a net profit margin of -7846.50%.
Frequently asked questions
BIOAF · 4 questionsBioasis Technologies Inc. (BIOAF) reported revenue of $0.00B for 2022, down 99.1% year-over-year.
BIOAF revenueBIOAF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09